John Brummer
Podiatrist, Foot & Ankle Surgery New York, NY Doctor of Podiatric Medicine
NPI 1437192457 CMS profile 19317
30 Broad St Ste 2005, New York, NY 10004
General payments
$35,416
Research payments
$0
Ownership & investment interest
$39,715
Through program year 2025, John Brummer of New York, NY is reported in the CMS Open Payments database as having received $35,416 across 251 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $39,715 across 4 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 94th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,849 | 29 | |
| 2024 | General | $2,588 | 12 | |
| 2023 | General | $1,857 | 22 | |
| 2022 | General | $5,231 | 29 | |
| 2021 | General | $12,407 | 43 | |
| 2020 | General | $3,794 | 41 | |
| 2019 | General | $7,692 | 75 | |
| 2022 | Ownership | $6,990 | 1 | |
| 2021 | Ownership | $11,645 | 1 | |
| 2020 | Ownership | $11,220 | 1 | |
| 2019 | Ownership | $9,860 | 1 |
Beside peers
- John Brummer
- Podiatrist, Foot & Ankle Surgery median
- Middle half of Podiatrist, Foot & Ankle Surgery
- National median
In program year 2025, general payments to John Brummer were reported at $1,849. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.
Show as a table
| Year | John Brummer | Podiatrist, Foot & Ankle Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,692 | $389 | $118–$1,406 | $163 |
| 2020 | $3,794 | $191 | $62–$691 | $114 |
| 2021 | $12,407 | $329 | $104–$1,341 | $132 |
| 2022 | $5,231 | $419 | $125–$1,611 | $149 |
| 2023 | $1,857 | $377 | $128–$1,164 | $160 |
| 2024 | $2,588 | $394 | $134–$1,168 | $164 |
| 2025 | $1,849 | $424 | $139–$1,306 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
251 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Podiatrist, Foot & Ankle Surgery in New York
George Vito
Podiatrist, Foot & Ankle Surgery · Le Roy, NY
Michael Keller
Podiatrist, Foot & Ankle Surgery · Kingston, NY
Stuart Mogul
Podiatrist, Foot & Ankle Surgery · New York, NY
Olatunde Osofisan
Podiatrist, Foot & Ankle Surgery · W Hempstead, NY
Kurt Relation
Podiatrist, Foot & Ankle Surgery · Slingerlands, NY
Deena Horn
Podiatrist, Foot & Ankle Surgery · New York, NY
Related records
Podiatrist, Foot & Ankle Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Podiatrist, Foot & Ankle Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.